{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Safety+Testing&page=58", "query": { "intervention": "Safety Testing", "page": 58 }, "page_size": 10 }, "pagination": { "page": 58, "page_size": 10, "total_count": 1471, "total_pages": 148, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Safety+Testing&page=59&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Safety+Testing&page=57&page_size=10" }, "source": "remote", "last_synced_at": "2026-11-01T19:21:07.579Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT03317392", "title": "Testing the Safety of Different Doses of Olaparib Given Radium-223 for Men With Advanced Prostate Cancer With Bone Metastasis", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Castration-Resistant Prostate Carcinoma", "Metastatic Prostate Adenocarcinoma", "Stage IVB Prostate Cancer AJCC v8" ], "interventions": [ { "name": "Biopsy Procedure", "type": "PROCEDURE" }, { "name": "Biospecimen Collection", "type": "PROCEDURE" }, { "name": "Computed Tomography", "type": "PROCEDURE" }, { "name": "Laboratory Biomarker Analysis", "type": "OTHER" }, { "name": "Magnetic Resonance Imaging", "type": "PROCEDURE" }, { "name": "Olaparib", "type": "DRUG" }, { "name": "Quality-of-Life Assessment", "type": "OTHER" }, { "name": "Radium Ra 223 Dichloride", "type": "RADIATION" } ], "intervention_types": [ "PROCEDURE", "OTHER", "DRUG", "RADIATION" ], "sponsor": "National Cancer Institute (NCI)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "MALE", "summary": "18 Years and older · Male only" }, "enrollment_count": 132, "start_date": "2019-02-04", "completion_date": "2027-02-16", "has_results": true, "last_update_posted_date": "2026-09-09", "last_synced_at": "2026-11-01T19:21:07.579Z", "location_count": 22, "location_summary": "La Jolla, California • Sacramento, California • New Haven, Connecticut + 17 more", "locations": [ { "city": "La Jolla", "state": "California" }, { "city": "Sacramento", "state": "California" }, { "city": "New Haven", "state": "Connecticut" }, { "city": "New Haven", "state": "Connecticut" }, { "city": "Fairway", "state": "Kansas" } ], "official_url": "https://clinicaltrials.gov/study/NCT03317392" }, { "nct_id": "NCT03495908", "title": "Regular Insulin vs Rapid Insulin Delivered by V-Go", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Type 2 Diabetes", "Type 2 Diabetes Mellitus" ], "interventions": [ { "name": "VGo", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "East Coast Institute for Research", "sponsor_class": "NETWORK", "healthy_volunteers": false, "eligibility": { "minimum_age": "21 Years", "maximum_age": null, "sex": "ALL", "summary": "21 Years and older" }, "enrollment_count": 136, "start_date": "2018-04-09", "completion_date": "2019-08-12", "has_results": true, "last_update_posted_date": "2021-03-02", "last_synced_at": "2026-11-01T19:21:07.579Z", "location_count": 2, "location_summary": "Jacksonville, Florida • Macon, Georgia", "locations": [ { "city": "Jacksonville", "state": "Florida" }, { "city": "Macon", "state": "Georgia" } ], "official_url": "https://clinicaltrials.gov/study/NCT03495908" }, { "nct_id": "NCT07723833", "title": "A Study to Investigate the Relative Bioavailability and Safety of Different Oral Formulations of Elecoglipron in Healthy Participants", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Healthy Participants" ], "interventions": [ { "name": "Elecoglipron Reference Formulation Dose A", "type": "DRUG" }, { "name": "Elecoglipron Test formulation 1 Dose A", "type": "DRUG" }, { "name": "Elecoglipron Reference Formulation Dose B", "type": "DRUG" }, { "name": "Elecoglipron Test formulation 1 Dose B", "type": "DRUG" }, { "name": "Elecoglipron Test formulation 2 Dose A", "type": "DRUG" }, { "name": "Elecoglipron Test formulation 2 Dose B", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "AstraZeneca", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "18 Years to 55 Years" }, "enrollment_count": 152, "start_date": "2026-07-27", "completion_date": "2026-11-18", "has_results": false, "last_update_posted_date": "2026-09-16", "last_synced_at": "2026-11-01T19:21:07.579Z", "location_count": 2, "location_summary": "Glendale, California • Brooklyn, Maryland", "locations": [ { "city": "Glendale", "state": "California" }, { "city": "Brooklyn", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT07723833" }, { "nct_id": "NCT07843940", "title": "A Study to Test Obrixtamig in Combination With Pumitamig in People With Advanced Small Cell Lung Cancer (Dareon®-Rosetta35)", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Extensive-stage Small Cell Lung Carcinoma", "Advanced Small Cell Lung Cancer" ], "interventions": [ { "name": "Obrixtamig", "type": "DRUG" }, { "name": "Pumitamig", "type": "DRUG" }, { "name": "Carboplatin", "type": "DRUG" }, { "name": "Etoposide", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Boehringer Ingelheim", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 55, "start_date": "2026-10-01", "completion_date": "2030-04-21", "has_results": false, "last_update_posted_date": "2026-10-13", "last_synced_at": "2026-11-01T19:21:07.579Z", "location_count": 5, "location_summary": "Miami, Florida • Boston, Massachusetts • East Brunswick, New Jersey + 2 more", "locations": [ { "city": "Miami", "state": "Florida" }, { "city": "Boston", "state": "Massachusetts" }, { "city": "East Brunswick", "state": "New Jersey" }, { "city": "New York", "state": "New York" }, { "city": "Nashville", "state": "Tennessee" } ], "official_url": "https://clinicaltrials.gov/study/NCT07843940" }, { "nct_id": "NCT01497938", "title": "Outpatient Study to Evaluate Safety and Effectiveness of the Low Glucose Suspend Feature", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Type 1 Diabetes" ], "interventions": [ { "name": "Medtronic MMT-754 Veo Insulin pump testing Low Glucose Suspend (LGS) feature", "type": "DEVICE" }, { "name": "Medtronic (NO LGS FEATURE ) using Paradigm® Revel™2.0 Pump", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Medtronic MiniMed, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "16 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "16 Years to 70 Years" }, "enrollment_count": 247, "start_date": "2011-12", "completion_date": "2013-06", "has_results": true, "last_update_posted_date": "2014-03-17", "last_synced_at": "2026-11-01T19:21:07.579Z", "location_count": 17, "location_summary": "Little Rock, Arkansas • Escondido, California • San Mateo, California + 14 more", "locations": [ { "city": "Little Rock", "state": "Arkansas" }, { "city": "Escondido", "state": "California" }, { "city": "San Mateo", "state": "California" }, { "city": "Aurora", "state": "Colorado" }, { "city": "West Palm Beach", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT01497938" }, { "nct_id": "NCT00065806", "title": "Atherosclerosis Prevention in Pediatric Lupus Erythematosus (APPLE)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Lupus Erythematosus, Systemic" ], "interventions": [ { "name": "Atorvastatin", "type": "DRUG" }, { "name": "Placebo atorvastatin", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Laura Schanberg", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "10 Years", "maximum_age": "21 Years", "sex": "ALL", "summary": "10 Years to 21 Years" }, "enrollment_count": 221, "start_date": "2003-09", "completion_date": "2009-12", "has_results": true, "last_update_posted_date": "2013-08-15", "last_synced_at": "2026-11-01T19:21:07.579Z", "location_count": 1, "location_summary": "Durham, North Carolina", "locations": [ { "city": "Durham", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT00065806" }, { "nct_id": "NCT05659147", "title": "Imaging Biomarkers of Pancreatic Function and Disease", "overall_status": "ENROLLING_BY_INVITATION", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Pancreatitis", "Diabetes Mellitus" ], "interventions": [ { "name": "Research MRI without administration of intravenous secretin", "type": "DIAGNOSTIC_TEST" }, { "name": "Research MRI with administration of intravenous secretin", "type": "DIAGNOSTIC_TEST" }, { "name": "Genetic Sequencing", "type": "GENETIC" }, { "name": "Blood Tests", "type": "DIAGNOSTIC_TEST" }, { "name": "Stool Tests", "type": "DIAGNOSTIC_TEST" }, { "name": "Survey Completion", "type": "OTHER" }, { "name": "Endoscopic pancreatic function tests (ePFTs)", "type": "DIAGNOSTIC_TEST" }, { "name": "Secretin", "type": "DRUG" } ], "intervention_types": [ "DIAGNOSTIC_TEST", "GENETIC", "OTHER", "DRUG" ], "sponsor": "Children's Hospital Medical Center, Cincinnati", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "5 Years", "maximum_age": "21 Years", "sex": "ALL", "summary": "5 Years to 21 Years" }, "enrollment_count": 195, "start_date": "2023-01-18", "completion_date": "2027-12", "has_results": false, "last_update_posted_date": "2026-03-18", "last_synced_at": "2026-11-01T19:21:07.579Z", "location_count": 1, "location_summary": "Cincinnati, Ohio", "locations": [ { "city": "Cincinnati", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT05659147" }, { "nct_id": "NCT04579913", "title": "A Multi-center, International Prospective Follow up Study", "overall_status": "TERMINATED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Benign Prostatic Hyperplasia (BPH)" ], "interventions": [ { "name": "Review of medical history, administration of questionnaires, uroflowmetry and PVR as measured by ultrasound", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Medi-Tate Ltd.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "MALE", "summary": "Male only" }, "enrollment_count": 17, "start_date": "2020-12-21", "completion_date": "2021-04-22", "has_results": false, "last_update_posted_date": "2021-04-29", "last_synced_at": "2026-11-01T19:21:07.579Z", "location_count": 4, "location_summary": "Pompano Beach, Florida • Manhattan, New York • New York, New York", "locations": [ { "city": "Pompano Beach", "state": "Florida" }, { "city": "Manhattan", "state": "New York" }, { "city": "New York", "state": "New York" }, { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT04579913" }, { "nct_id": "NCT03347188", "title": "A Study to Test if Fremanezumab Reduces Headache in Participants With Posttraumatic Headache (PTH)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Post-Traumatic Headache" ], "interventions": [ { "name": "Fremanezumab", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Teva Branded Pharmaceutical Products R&D, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "18 Years to 70 Years" }, "enrollment_count": 87, "start_date": "2017-12-18", "completion_date": "2020-06-03", "has_results": true, "last_update_posted_date": "2022-12-13", "last_synced_at": "2026-11-01T19:21:07.579Z", "location_count": 33, "location_summary": "Phoenix, Arizona • Scottsdale, Arizona • Little Rock, Arkansas + 29 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Scottsdale", "state": "Arizona" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Long Beach", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT03347188" }, { "nct_id": "NCT07851103", "title": "A Study to Test Different Doses of BI 3968621 When Given Alone or With Ezabenlimab in Patients With Advanced Cancer", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Advanced Solid Tumour" ], "interventions": [ { "name": "BI 3968621", "type": "DRUG" }, { "name": "ezabenlimab", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Boehringer Ingelheim", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 90, "start_date": "2026-10-26", "completion_date": "2030-09-03", "has_results": false, "last_update_posted_date": "2026-10-28", "last_synced_at": "2026-11-01T19:21:07.579Z", "location_count": 5, "location_summary": "Sarasota, Florida • Atlanta, Georgia • Philadelphia, Pennsylvania + 2 more", "locations": [ { "city": "Sarasota", "state": "Florida" }, { "city": "Atlanta", "state": "Georgia" }, { "city": "Philadelphia", "state": "Pennsylvania" }, { "city": "Nashville", "state": "Tennessee" }, { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT07851103" } ] }